Andover, MA, United States of America

Anthony H Cincotta

USPTO Granted Patents = 88 

 

 

Average Co-Inventor Count = 1.5

ph-index = 31

Forward Citations = 2,424(Granted Patents)


Inventors with similar research interests:


Location History:

  • Baton Rouge, LA (US) (1987 - 1998)
  • Andover, MA (US) (1994 - 2000)
  • Charlestown, MA (US) (1997 - 2005)
  • Tiverton, RI (US) (2011 - 2024)

Company Filing History:


Years Active: 1987-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Tumor Regression
Bromocriptine Formulations
Metabolic Disorders
Dopamine Receptor Agonists
Parenteral Formulations
Metabolic Syndrome
Type 2 Diabetes
Obesity
Insulin Secretagogues
Neoplastic Disease
Rheumatoid Arthritis
Immune Function Regulation
88 patents (USPTO):Explore Patents

Title: Anthony H Cincotta: Innovating Boundaries and Revolutionizing Industries

Introduction:

Throughout his career, Anthony H Cincotta has consistently demonstrated his innovative prowess, pushing the boundaries of technology and making significant contributions to various industries. His dedication has led to the development of groundbreaking solutions that have garnered recognition and acclaim. In this article, we will delve into his career highlights and explore some of his latest patents that have transformed the field of healthcare.

Latest Patents:

One of Anthony H Cincotta's recent patents is related to bromocriptine formulations. These pharmaceutical formulations aim to treat physiological disorders, particularly focusing on improving glycemic control in the treatment of type 2 diabetes. The patent also encompasses the synthesis of bromocriptine citrate and the creation of compositions and dosage forms containing it. This breakthrough in medical science has the potential to revolutionize the treatment of metabolic disorders and enhance the quality of life for individuals worldwide.

Career Highlights:

Anthony H Cincotta's career is filled with numerous milestones that speak to his unwavering commitment to innovation. With an impressive record of 85 patents, he has consistently pioneered advancements across diverse industries. His passion and expertise have not only influenced the field of healthcare but have also left a prominent mark in other areas, including technology and engineering. Cincotta's relentless pursuit of excellence has made him a true trailblazer in his field.

Collaborations:

Throughout his journey, Anthony H Cincotta has had the privilege of collaborating with some exceptional individuals and organizations. Notable among his coworkers are Albert H Meier and Craig Michael Bowe, who have played crucial roles in realizing their shared vision of transforming industries. These partnerships have strengthened the impact of their innovative solutions, working collectively to revolutionize various sectors.

Conclusion:

Anthony H Cincotta's career showcases a story of constant innovation, dedication, and groundbreaking achievements. With his numerous patents and groundbreaking research, he has made enduring contributions to multiple industries. His transformative work in developing bromocriptine formulations for treating metabolic disorders, especially type 2 diabetes, is evidence of his unwavering commitment to improving human health. As we look towards the future, Cincotta's legacy will undoubtedly continue to inspire and shape the landscape of innovation and patents.

To explore more about Anthony H Cincotta and his exceptional career, please visit our website, idiyas.com, where you will find detailed information about his accomplishments, collaborations, and inventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…